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Introduction
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Positron-Emission-Tomography (PET), a "molecular imaging" technology, is a medical imaging technique that utilizes radioactively labelled molecules (PET tracers) that are tailored to interact with biological processes in vivo. 1 After injection into the patient, a PET tracer shall accumulate at areas of interest 30 according to its pharmacokinetic properties. Subsequently, the resulting radioactivity distribution in the patient is measured utilizing a PET scanner, today commonly in combination with anatomic image acquisition from computer tomography (PET/CT) or magnetic resonance imaging (PET/M R). Regardless 35 of the imaging device utilized, the majority of the resulting diagnostic information is determined by the biological or ____________________________________________________ 60 dopamine D2/D3 receptors). Therefore, new PET tracers are currently under development by academic and industrial entities. A major challenge associated with the transfer of this increasing variety of radioactively labelled molecules into clinical practice is the infrastructural burden associated with the synthesis of PET 65 tracers. Today, this step is performed by automated synthesis devices ("synthesizers") utilizing conventional valves, tubing and glass vessels inside a lead shielded work space ("hot cells"). One hot cell can result in a weight of 8 tons while requiring a class C clean room environment of approx. 1000 litres according to 70 regulatory requirements. This leads to significant costs and infrastructural constraints for PET site erection, modification and routine PET tracer production. Furthermore, state of the art synthesizers utilize reagent volumes from several hundred microliters to a few millilitres for reasons of practicality. These 75 volumes are several orders of magnitude above the theoretically required amount, since PET tracers are functional in nanomolar quantities of the radioactively labelled molecules. Intuitively, microfluidic technology was introduced to the field, targeting a down-scaling of synthesizers to enable reduced 80 shielding size and weight as well as more efficient chemical processing. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] For about one decade, numerous microfluidic PET tracer synthesis setups have been described including commercially available capillary -based microfluidic synthesis platforms, [14] [15] [16] as well as lab-on-chip devices. [17] [18] [19] [20] [21] [22] Significant improvements to PET tracer synthesis were demonstrated such as reduced reaction times due to fast heat transfer and high surface to volume ratios in microfluidics, low consumption of potentially expensive reagents, fast optimization of reaction conditions and 5 low volume processing of radioactivity levels sufficient for practical use. However, the large characteristic dimensions (including all hardware periphery) of the microfluidic setups presented as well as the system complexity exposed to the operator have remained 10 two major obstacles towards routine use. Furthermore, PDM Sbased chip designs that capitalize on highly integrated valves have been questioned due to the incompatibility of PDM S to fluoride-18 based radiochemistry. 49 This study tackles those challenges and presents a radiochemistry 15 system that unites all technical elements required for a simple PET tracer synthesis in one compact, easy to use device. First and foremost this includes a chip material with full compatibility to process reagents and temperatures. Second, the utilization of this material is enabled by a chip manufacturing technology with a 20 perspective towards economy of scale. Third, functional elements required for the execution of the synthesis workflow are implemented into the chosen chip material technology . These functional elements are on-chip microfluidic reactors, on-chip fluid and gas control by means of on-chip valves and associated 25 compact off-chip valve actuators, on-chip solid phase exchange (SPE) and a connector interface between the chip and the hardware periphery. To improve ease of use, the chip to hardware interface is designed for full automation, enabling seamless chip loading and unloading in a single motion. Reagents are 30 transferred from low dead-volume vials across the interface by means of gas pressure driven fluid transport. All described elements are integrated into a hardware assembly that has a perspective towards compact shielding architectures. The functionality of the platform is exemplarily demonstrated by the 35 complete synthesis of a Polyethylenglycol-derivatized (PEGylated) Bombesin BN(7-14)-derivative ([ 18 F]PESIN).
Materials and Methods
Fundamental considerations
The ultimate target of synthesizing a PET tracer on a microfluidic 40 system in a routine environment is to provide a PET image to a medical doctor at an acceptable cost. 50 In this context, the most important key figure is "cost per (PET) dose", which rolls up all elements of PET facility installation and operation. Accordingly, cost is critical for the microfluidic synthesizer as a system (e.g. 45 reduced installation cost by means of reduced shielding installation) as well as its operation (e.g. cost of consumables).
Currently there are two fundamental microfluidic system architectures in radiochemistry: Chip -based and capillary-based synthesizers. The advantage of chip-based microfluidic devices is 50 seen in the capability for cross-contamination-free production of various PET tracers in series with no need for manual hardware re-configuration or cleaning between runs and therefor full compliance to regulatory requirements. In this case, the microfluidic chip is a replaceable, single-use consumable, 55 comparable to current synthesizers that are utilizing disposable fluid path manifolds ("cassettes") and a set of reagents ("reagent kits") that may be produced in separate or as combined cassettes with integrated reagents (e.g. GE FASTlab, GE Healthcare, Liege, Belgium). Today, one cassette and one reagent kit is often 60 used for the synthesis of PET tracer "batches" that serve several patients at once, leading to a reduced contribution of consumables cost to the cost per PET tracer dose. In contrast, the major application of microfluidic PET tracer synthesizers is seen in the area of small patient groups (<10) that 65 either require PET tracers "on demand" or are located at hospitals with limited connectivity to PET tracer distribution networks, also referred to as "de-centralized" production sites. 7 Hence, the manufacturing cost target for a single microfluidic consumable including reagents has to be expected at a fraction of today's 70 consumables cost. Based on the number of existing PET facilities worldwide and the limited growth of reimbursement for PET, the number of chips required globally per year is estimated to be a few hundred thousand. Both, the high cost pressure on consumables and the number of parts per year place significant 75 limitations on the materials and manufacturing methods that can be employed to realize a lab-on-chip consumable that is commercially viable.
Microfluidic chip manufacturing
According to the cost constraints described, a materials study was 80 conducted and published in previous work. 49 From this study, injection mouldable cyclic olefin co-polymers (COC) were selected. Injection moulding and embossing are cost effective methods for manufacturing of microfluidic parts down to submicron geometric accuracy at a low production cycle time per 85 part. 51, 52 COC is compatible with many reagents utilized in radiochemistry including strong acids (e.g. hydrochloric acid), bases (e.g. sodium hydroxide), polar organic solvents (e.g. dimethyl sulfoxide, acetonitrile or dimethylformamide) and alcohols (e.g. ethanol). Beyond the room temperature Silicon assembled together with the elements for on-chip valve and onchip resin integration. The assembly process was designed with a perspective to cost effective pick-and-place automation.
After assembly, all chip elements are joined in a single thermal bonding step. No additional cleaning, surface treatment, adhesives, ultrasound nor laser processes are required.
On-chip valve
Due to the need for organic solvent compatibility (e.g. dimethyl 5 formamide or dimethyl sulfoxide), common microfluidic valve designs that rely on flexible membrane materials such as PDM S or Viton ® are not suitable.
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The membrane valve developed in this study utilizes a floating FEP disk (DuPont FEP, part No. #536-3996, RS Components 10 GmbH, Germany) encapsulated by the chip substrate (COC 6017) and a 100µm thick cover membrane (COC 6015). 59 The valve inlet and outlet can be prototyped utilizing high precision milling techniques and are suitable for injection moulding. Due to the materials (COC and FEP) utilized, the valve is compatible to The valve design was characterized under realistic conditions of use in terms of maximum pressure capability and repeatable performance across 50 opening and closing cycles. The valve leakage rate was determined by a simplified test applying gas pressure to the valve inlet and subsequent observation of bubble 30 formation at the valve outlet.
On-chip resin
The synthesis of PET tracers often requires functional resins for the initial transfer of the radioactive fluoride-18 from aqueous to aprotic reaction conditions and for intermediate as well as final 35 product purification. Several techniques have been reported including manual filling of on-chip cavities, 60 on-chip trapping of solution suspended beads 19 as well as introduction, photoinitiated polymerization and functionalization of reactive compounds for monolithic on-chip columns. 61 Even though there 40 have been successful efforts to reduce the need for SPE-based process steps by means of electrochemical methods [62] [63] [64] [65] [66] [67] [68] [69] or continuous flow microfluidics, 70 the challenge remains for product purification, resulting in custom made micro-columns external to the microfluidic chip. 17, 18, 71 Future on-chip 45 alternatives may involve periodic micro-structures such as pillar arrays 72 as well as functional surfaces. However, all methods described impose challenges on process chemistry, repeatability, compatibility with established synthesis routines, reagent volumes and throughput, manufacturing complexity and economy 50 of scale. The resin integration method proposed in this work utilizes an insert element that is pre-filled with conventional resins, separating the integration workflow into three steps: a) resin transfer to a low-cost carrier element (insert body, compare The silica-based resin material is extracted from the respective standard cartridges and manually transferred to the COC 6015 insert bodies creating phase transfer inserts and purification inserts. Prior to bonding, the pre-assembled inserts are manually positioned into milled recesses between the three microfluidic 5 chip layers, whereas each insert is slightly smaller in two (X and Y) and larger in one dimension (Z) than the recess. After chip assembly, the COC 6015 insert is thermo-formed into the recess during chip bonding. This approach capitalizes on the different glass transition temperatures between COC 6015 (HDT/B=150 10 °C) and COC 6017 (HDT/B=170 °C). The required thermoforming pressure is provided by the geometric mismatch between the insert and the on-chip recess and has to be adjusted based on insert size. The on-chip cartridges can be varied in number, packaged resin 15 size and location on the chip during chip design. For future high volume production, cartridge manufacturing can be standardized and manual assembly step s may be replaced by e.g. pick-andplace automation.
Chip interface for liquids and gases
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The micro-to macro interface is a known challenge of microsystems and numerous microfluidic connectors have been described in the literature. 73 However, most solutions are not compatible with the chemicals employed in PET chemistry or are challenging to connect in an automated fashion due to a multi 25 component design involving O-rings, screws or adhesives. Conventional high performance liquid chromatography (HPLC) fittings capitalize on the mechanical advantage of a wedge. The same principle is applied to the design presented in this study utilizing conventional conical ferrules (F-142N ETFE ferrules, Techlab GmbH, Germany) which are compressed into conic 35 recesses on chip. 74 At an on-chip cone opening angle of 42°
(recess depth 1.5mm) a compression force of 20N between ferrule and chip was found sufficient to achieve liquid sealing (2-propanol) up to a pressure of 100bar. In order to compensate for mechanical misalignment during automated chip loading and 40 cross forces resulting from thermal expansion of the chip when operated at elevated temperatures, a compensation mechanism 75 has been implemented (Fig. 2) . By this design, sealing is achieved across 16 fluid ports and multiple opening and closing cycles. Similar to the valve actuators, connectivity between the 45 chip and the hardware is achieved in a single automated motion.
Reagent supply and loading
The gold standard for reagent storage in radiochemistry are septa capped glass vials since this method is compatible to long term storage of solvents such as DM SO. Accordingly, reagents at a 50 volume range between 50µl and 2ml are provided to the platform from septa capped low dead-volume vials (Certified CD™ Vial, part No. 29307-U, Supelco Analytical, USA). Since conventional Luer adapters show dead volumes >10µl, the vials are interfaced by a custom built low dead volume connector. Each vial is 55 connected via the adapter to the chip interface using a single PEEK capillary line respectively. This line is utilized for gas pressurization of the vial as well as subsequent pressure driven unloading of the reagent to the chip. Only on-chip valves are utilized to switch between vial pressurization and reagent 60 unloading, minimizing the number of transfer lines and the associated interface complexity as well as the risk of leakages. On-chip, reagents are driven by gas pressure in case accurate metering of flow rates is not required (e.g. application of aqueous activity to QM A cartridge). For accurate metering (e.g. precise 65 mixing during HEPES buffer dilution), two or more syringe pumps of the control box can be employed utilizing e.g. acetonitrile as mediators between the reagents to be controlled on-chip and the syringe pump.
Compact control hardware 70 The control hardware can be separated into two sub-systems: (1) the chip manifold and (2) the control device (Fig. 3) . This arrangement is chosen with a perspective towards "splitbox" or "self-shielded" architectures which provide shielding only to system elements in contact with radioactive reagents, in this case the chip and the surrounding chip manifold. 32 This approach is superior to conventional hot cell designs in terms of 80 weight, space consumption, installation cost and flexibility. The chip manifold contains the fluid interface with 16 input/output (I/O) ports and the valve actuator assembly (Fig. 4) . After manual chip insertion, the valve actuator interface automatically compresses the chip against the fluid interface by 85 means of a motor driven mechanism, enabling a connection of all chip control elements with one move.
Heating blocks enabling on-chip process operation at temperatures of up to 150°C were integrated into the setup but not used in this study. A mechanism for chip ejection after process completion has been integrated in order to demonstrate a line of sight towards automated disposal of contaminated chips into shielded waste areas for seamless "back-to-back" operation of consecutive synthesis runs at low radiation exposure to the operator. separates the synthesis workflow into process steps, whereas within each process step all system parameters can be controlled and monitored. For a PET tracer synthesis, a sequence of process steps can be programmed, saved, loaded and modified, enabling full design flexibility to the operator. Sequences can be executed 25 automatically or between user-defined breakpoints with the option of process step or sequence modifications "on the fly".
Proof-of-concept for S iFA radiochemistry
The radiolabeling of a PET tracer according to the SiFA method was chosen as proof-of-concept example. The SiFA approach 30 allows for a highly efficient isotopic exchange reaction that simplifies the synthesis workflow by enabling cartridge-based drying of fluoride-18. [76] [77] [78] [79] [80] Bombesin analogues are imaging probes for oncological applications. They are ligands of the gastrin-releasing-peptide 35 receptor (GRP-R) which is overexpressed on several tumor tissues such as prostate, breast, ovarian, lung, colon and gastrinoma cancers and therefore a feasible target structure for tumor visualization with PET. [81] [82] [83] The Bombesin derivative PESIN was tagged with a SiFA moiety and radiolabeled on the 40 microfluidic platform according to the following steps: (1) Loading of all reagents including aqueous fluoride-18 activity from vials, (2) fluoride-18 phase transfer from aqueous to aprotic reaction conditions, (3) radiolabeling, (4) purification and (5) ejection of the radiolabelled [
18 F]PESIN PET tracer into a 45 product vial.
Results
Microfluidic chip
Depending on microfluidic structure complexity, the total milling time per chip layer including loading and unloading of blanks 50 varied between 20 min and 120 min. Without further optimization, the thermal bonding time was adjusted to 45min and yielded chips without delamination defects. In this way, different chip designs can be explored rapidly during chip development with high degrees of design flexibility for 55 interconnecting valves, resins, reactors and I/O ports on-chip. Towards economy of scale, improvements can be achieved by customized injection moulding and solvent assisted bonding for rapid and cost effective chip manufacturing. During and after handling of acetonitrile, DM F, DM SO or 60 ethanol on-chip, no change in material color, transparency, material abrasion or swelling was observed. No significant chemical interaction was found between the chip material and the fluoride-18 radioactivity nor any other reagent or intermediate product utilized during the radiosynthesis described. Several test 65 chips were operated at up to 140°C resulting in no structural defects. This is consistent with results reported in previous studies for DM SO at 113°C and HCl (1M ) at 80°C. 
On-chip valve
Valve test structure fatigue was measured at an average gas 70 pressure load of 5.8 bar (min. 4.1 bar, max. 6.2 bar, standard deviation 0.6 bar, 44 samples, pressure ramp up time 320s ± 30s). Improvements towards increased pressure capabilities can be achieved by a further reduction of the valve diameter below 6 mm. 75 Valve cycle tests resulted in zero valve failure across 50 switching cycles (n = 37 valves from 8 different test chips investigated), which is the maximum load estimated for a single PET tracer synthesis run on a chip -based consumable. No change or cycle dependent drift was detected for the closing force or the 80 gas flow rate across the open valve. This suggests that the valve functionality is not significantly affected by wearing effects such as membrane damage or valve seat deformation across 50 cycles. During gas leakage measurements, no gas bubble formation could be detected across a 1.0 min measurement time, suggesting a gas 85 leakage rate < 0.1µl/min at 2 bar gas pressure and 4N closing force on the valve plunger.
On-chip resin
For the evaluation of on-chip resin performance, insert elements are packed with the anion exchange resin material from ø4mm, 46mg resin), the results suggest a deformation of the insert element and a subsequent compression of the resin during bonding. This effect could be compensated by appropriate tolerance design between the insert size and the on-chip recess size prior to bonding as outlined before. 
Reagent loading
The transfer efficiency for aqueous fluoride-18 from vial to chip 20 according to the described gas pressurization method for starting volumes ranging from 100µl to 500µl at initial activities between 386 M Bq (10.4 mCi) to 720 M Bq (19.5 mCi) was measured at an average of 97.8% (max. 99.6%, min. 93.5%, standard deviation 1.6%, 17 samples), based on the comparison of vial activity 25 before and after fluoride-18 loading to chip, decay corrected to the start of the experiment. Being the easiest quantifiable reagent for reagent transfer characterization, the aqueous 18-fluoride loading shows the efficiency of the presented approach and suggests a good transfer of the other vial supplied reagents 30 utilized in the process. In fact, no synthesis failures from a lack of e.g. precursor or oxalic acid in the process could be detected.
Chemistry results
The total process efficiency, which is described by the fraction of fluoride-18 activity transferred from the starting vial (start of 35 synthesis, SOS) into the purified [ 18 F]PESIN product, yielded 33% (±3%) (n=4, not decay corrected) at >99% radiochemical purity (Agilent 1200 radio-HPLC, Agilent Technologies Inc., USA) at starting activities between 243 M Bq (6.6mCi) and 394 M Bq (10.6 mCi). This overall efficiency is slightly below the 40 manual equivalent process (approx. 40% overall efficiency at >99% radiochemical purity , not decay corrected). The total process time was optimized to 36 min. Residual activity on-chip after synthesis completion without optimization of on-chip structures nor use of wash protocols was measured to <14% 45 across all runs (decay corrected to SOS). The described results were accomplished for a chip design with cartridges external to the chip, connected via capillary tubing across the described connector interface. In a separate proof-of-concept experiment, both cartridges were 50 transferred on-chip while maintaining the remaining chip design identical to the previous experiment (Fig. 6 ). This resulted in an overall process efficiency of 12% (not decay corrected) at >99% radiochemical purity in the first run. This is comparable to the early performance of the cartridge off-chip setup prior to 55 chemistry protocol optimization. The discrepancy results from the previously described on-chip resin compression during bonding which led to incorrect timing for mixing of reagents on-chip. This can be addressed by chemistry protocol optimization and improved cartridge insert 60 design, suggesting that performance comparable to conventional processing is achievable. 
Platform hardware
During test and evaluation of the microfluidic chemistry platform for the SiFA chemistry, chips have been successfully loaded and unloaded into the automated hardware over more than 100 cycles. Occasional leakage of the Tefzel Ferrules at the I/O ports due to 70 deformation of the ferrule could be addressed by simple ferrule replacement. Even though the chips are design as single use disposable, they were used multiple times in case cartridges were off-chip. Gas pressure test p rotocols have been employed to ensure system functionality prior to start of a synthesis. The 75 platform was easy to move between fume hoods, hot cells and test sites in Europe and the United States at an average setup time of < 30 min. after relocation. Radiochemistry users could be trained to operate the system within approx. one week.
Conclusion
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With the recent FDA approval of new radiotracers for diagnosis of Alzheimer's disease such as Vizamyl TM (GE Healthcare, USA) and Amyvid TM (Eli Lilly, USA), the development of compact cyclotrons (ABT M olecular Imaging, Inc., Louisville, TN, USA 85 and PETtrace 600 prototype, GE Healthcare, Uppsala, Sweden) 85 and integrated quality control systems for PET tracer production (QC1, M ünster, Germany), the area is more vibrant than ever before. Cost per PET tracer dose is the main driver towards PET imaging for small and de-central hospitals worldwide. Hence, the 5 objective of this study was not to demonstrate microfluidic effects that push radiochemistry reactions to the extreme, which is another reason why microfluidics is of interest in this field, but rather develop an overall system solution that fundamentally enables cost saving microfluidic technologies to the clinical 10 routine. Entering the development based on process compatible COC materials, the resulting chip maintains compatibility to large scale manufacturing by means of injection moulding and integration of all functional elements required for a simple PET tracer synthesis workflow. Pragmatic but viable solutions have 15 been presented for on-chip valve and on-chip resin integration. Interfacing to "the macro world", the microfluidic chip has been made accessible by a hardware interface that enables a reliable and automated chip exchange. The fully automated synthesis of the PET tracer [ 18 F]PESIN has been successfully implemented as 20 a proof-of-concept study at yields close to the conventional process. Due to its compactness, the microfluidic radiochemistry platform including all hardware components can be easily relocated while providing a system architecture which is fundamentally compatible to very compact "self-shielded" 25 designs. In its current state and with the prototype manufacturing for chips established, the platform is ready for field tests with academic partners around the globe in order to implement new PET tracer synthesis routines. Looking beyond applications in PET radiochemistry, the presented microfluidic chemistry 30 platform can be extended to other areas in chemistry and biology that require chip consumables with high temperature and aggressive chemistry requirements.
